Oscars of Science: 2026 Breakthrough Prize celebrates major advances in sciences

On April 18, 2026, the Breakthrough Prize Foundation, often dubbed the "Oscars of Science," announced this year's laureates in Life Sciences, Fundamental Physics and Mathematics, honoring groundbreaking discoveries, including advances in gene therapy, neurodegenerative diseases and nonlinear evolution equations. Co-founded by science and technology leaders such as Mark Zuckerberg, Sergey Brin and Anne Wojcicki, the Breakthrough Prize, now in its 14th year, celebrates scientific excellence. This year's ceremony is being held in Los Angeles.

In the Life Sciences category, Jean Bennett, Katherine A. High and Albert Maguire share the prize for developing the first FDA-approved gene replacement therapy for Leber congenital amaurosis, a rare inherited retinal disease that can lead to early vision loss. Their work restores vision in affected children, giving them the chance for independent living and normal childhood experiences.

Stuart H. Orkin and Swee Lay Thein are honored for developing gene-editing therapies to treat previously incurable blood disorders, including sickle cell disease and beta-thalassemia.

Rosa Rademakers and Bryan Traynor are recognized for independently discovering a key genetic cause of both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), the second leading cause of early-onset dementia. Their findings link these previously separate diseases and open the door to genetic testing and potential therapies.

These breakthroughs highlight how advances in gene and molecular research are transforming medicine, offering new pathways for treatment and hope to patients worldwide.